Exhibit 2.1
EXECUTION COPY
AGREEMENT AND PLAN OF
AMALGAMATION
Dated as of July 9,
2009
Among
IPC HOLDINGS, LTD.,
VALIDUS HOLDINGS, LTD.
And
VALIDUS LTD.
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I
|
|
|
THE AMALGAMATION
|
|
|
|
|
1.1
|
|
The
Amalgamation; Effective Time
|
|
1
|
|
1.2
|
|
Closing
|
|
2
|
|
1.3
|
|
Effects of the
Amalgamation
|
|
2
|
|
1.4
|
|
Amalgamated
Company Bye-laws
|
|
2
|
|
1.5
|
|
[Reserved]
|
|
2
|
|
1.6
|
|
Directors and
Officers of the Amalgamated Company
|
|
2
|
|
1.7
|
|
Amalgamated
Company Name
|
|
3
|
|
|
ARTICLE II
|
|
|
CONVERSION OF IPC SECURITIES;
EXCHANGE OF CERTIFICATES
|
|
|
|
|
2.1
|
|
Effect on Share
Capital
|
|
3
|
|
2.2
|
|
Exchange
Procedures
|
|
4
|
|
2.3
|
|
IPC Equity
Awards
|
|
6
|
|
ARTICLE III
|
|
|
REPRESENTATIONS AND
WARRANTIES
|
|
|
|
|
3.1
|
|
Organization,
Standing and Power
|
|
8
|
|
3.2
|
|
Capital
Structure
|
|
9
|
|
3.3
|
|
Authority;
Non-Contravention
|
|
10
|
|
3.4
|
|
SEC Documents;
Regulatory Reports; Undisclosed Liabilities
|
|
11
|
|
3.5
|
|
Compliance with
Applicable Laws and Reporting Requirements
|
|
12
|
|
3.6
|
|
Legal and
Arbitration Proceedings and Investigations
|
|
13
|
|
3.7
|
|
Taxes
|
|
13
|
|
3.8
|
|
Absence of
Certain Changes or Events
|
|
15
|
|
3.9
|
|
Board
Approval
|
|
15
|
|
3.10
|
|
Vote
Required
|
|
16
|
|
3.11
|
|
Agreements with
Regulators
|
|
16
|
|
3.12
|
|
Insurance
Matters
|
|
17
|
|
3.13
|
|
Investments;
Derivatives
|
|
21
|
|
3.14
|
|
Material
Contracts; Intercompany Contracts
|
|
21
|
|
3.15
|
|
Employee
Benefits and Executive Compensation
|
|
22
|
|
3.16
|
|
Labor Relations
and Other Employment Matters
|
|
23
|
|
3.17
|
|
Intellectual
Property
|
|
24
|
|
3.18
|
|
Properties
|
|
25
|
|
3.19
|
|
Brokers or
Finders
|
|
25
|
|
3.20
|
|
Investment
Advisor
|
|
25
|
|
3.21
|
|
Opinion of
Financial Advisor
|
|
25
|
|
3.22
|
|
Takeover
Laws
|
|
25
|
|
3.23
|
|
Termination of
Max Agreement
|
|
26
|
-i-
|
|
|
|
|
|
ARTICLE IV
|
|
|
COVENANTS RELATING TO CONDUCT OF
BUSINESS
|
|
|
|
|
4.1
|
|
Covenants of
Validus and IPC
|
|
26
|
|
4.2
|
|
Financing
|
|
29
|
|
4.3
|
|
Bermuda
Required Actions
|
|
29
|
|
|
ARTICLE V
|
|
|
ADDITIONAL AGREEMENTS
|
|
|
|
|
5.1
|
|
Preparation of
Joint Proxy/Prospectus; Shareholders Meetings
|
|
29
|
|
5.2
|
|
Access to
Information; Confidentiality
|
|
31
|
|
5.3
|
|
Commercially
Reasonable Efforts
|
|
32
|
|
5.4
|
|
No Change in
Recommendation
|
|
33
|
|
5.5
|
|
Acquisition
Proposals
|
|
34
|
|
5.6
|
|
Section 16
Matters
|
|
37
|
|
5.7
|
|
Fees and
Expenses
|
|
37
|
|
5.8
|
|
Indemnification; Directors’ and
Officers’ Insurance
|
|
37
|
|
5.9
|
|
Public
Announcements
|
|
38
|
|
5.10
|
|
Additional
Agreements
|
|
38
|
|
5.11
|
|
Shareholder
Litigation
|
|
38
|
|
5.12
|
|
Employee
Benefits
|
|
38
|
|
5.13
|
|
Listing and
Delisting; Reservation for Issuance
|
|
39
|
|
5.14
|
|
Dividends
|
|
39
|
|
5.15
|
|
Tax
Treatment
|
|
40
|
|
5.16
|
|
Max Termination
Fee
|
|
40
|
|
5.17
|
|
Validus
Proposals
|
|
40
|
|
5.18
|
|
Certain Max
Litigation
|
|
40
|
|
5.19
|
|
Requisition
Meeting
|
|
41
|
|
|
ARTICLE VI
|
|
|
CONDITIONS PRECEDENT
|
|
|
|
|
6.1
|
|
Conditions to
Each Party’s Obligation to Effect the Amalgamation
|
|
41
|
|
6.2
|
|
Conditions to
Obligation of IPC
|
|
41
|
|
6.3
|
|
Conditions to
Obligation of Validus
|
|
43
|
|
|
ARTICLE VII
|
|
|
TERMINATION AND AMENDMENT
|
|
|
|
|
7.1
|
|
Termination
|
|
44
|
|
7.2
|
|
Effect of
Termination
|
|
45
|
|
7.3
|
|
Repayment of
the Reimbursement Amount
|
|
46
|
-ii-
|
|
|
|
|
|
ARTICLE VIII
|
|
|
GENERAL PROVISIONS
|
|
|
|
|
8.1
|
|
Non-Survival of
Representations, Warranties and Agreements
|
|
48
|
|
8.2
|
|
Notices
|
|
48
|
|
8.3
|
|
Interpretation
|
|
49
|
|
8.4
|
|
Counterparts
|
|
49
|
|
8.5
|
|
Entire
Agreement; No Third Party Beneficiaries
|
|
49
|
|
8.6
|
|
Governing
Law
|
|
50
|
|
8.7
|
|
Severability
|
|
50
|
|
8.8
|
|
Assignment
|
|
50
|
|
8.9
|
|
Enforcement
|
|
50
|
|
8.10
|
|
Submission to
Jurisdiction
|
|
50
|
|
8.11
|
|
Amendment
|
|
51
|
|
8.12
|
|
Extension;
Waiver
|
|
51
|
|
8.13
|
|
Defined
Terms
|
|
51
|
|
|
|
|
Exhibit A
|
|
Amalgamation
Agreement
|
|
Exhibit B
|
|
IPC Bye-Law
Amendment
|
-iii-
AGREEMENT AND PLAN OF AMALGAMATION,
dated as of July 9, 2009 (this “ Agreement
”), among IPC HOLDINGS, LTD., a Bermuda exempted company
(“ IPC ”), VALIDUS HOLDINGS, LTD., a Bermuda
exempted company (“ Validus ”) and VALIDUS LTD.,
a Bermuda exempted company and a wholly owned subsidiary of Validus
(“ Amalgamation Sub ”).
WHEREAS, the board of directors of
IPC has adopted this Agreement and the Amalgamation Agreement (as
defined in Section 1.1) and authorized and approved the
amalgamation of IPC with Amalgamation Sub upon the terms and
subject to the conditions set forth herein (the “
Amalgamation ”), authorized and approved the IPC
Bye-Law Amendment (as defined in Section 3.9(a)) and deems it
fair to, advisable to and in the best interests of IPC to enter
into this Agreement and to consummate the Amalgamation and the
other transactions contemplated hereby;
WHEREAS, the board of directors of
Validus has adopted this Agreement, authorized and approved the
issuance of Validus Common Shares (as defined in
Section 2.1(a)) in the Amalgamation (the “ Share
Issuance ”) and deems it fair, advisable and in the best
interests of Validus to enter into this Agreement and to consummate
the Share Issuance and the other transactions contemplated
hereby;
WHEREAS, the board of directors of
Amalgamation Sub has adopted this Agreement, authorized and
approved the Amalgamation, and deems it advisable and in the best
interests of Amalgamation Sub to enter into this Agreement and to
consummate the Amalgamation and the other transactions contemplated
hereby;
WHEREAS, in accordance with
IPC’s and Validus’ desire to consummate the
Amalgamation, Validus is withdrawing its previously announced
exchange offer for the common shares of IPC;
WHEREAS, this Agreement is being
entered into in accordance with the Bermuda Companies Act of 1981,
as amended (the “ Companies Act ”);
WHEREAS, IPC, Validus, and
Amalgamation Sub desire to make certain representations, warranties
and agreements in connection with the Amalgamation and also to
prescribe various conditions to the Amalgamation;
WHEREAS, it is intended that this
Agreement shall constitute a “plan of reorganization,”
within the meaning of Section 354 of the Internal Revenue Code
of 1986, as amended (the “ Code ”);
WHEREAS, following the execution and
delivery of this Agreement, IPC is paying $50,000,000 to Max
Capital Group Ltd. (“ Max ”) in respect of the
Max Termination Fee (as defined in Section 4.1(a)) and Validus
is paying $50,000,000 to IPC in respect of, and in reliance upon,
such payment by IPC to Max; and
WHEREAS, concurrently with the
execution of this Agreement, as an inducement to IPC’s
willingness to enter into this Agreement, IPC has entered into a
Voting Agreement with each of the Specified Validus Shareholders
(as defined in Section 8.13(a)).
NOW, THEREFORE, in consideration of
the foregoing and the respective representations, warranties,
covenants and agreements set forth herein, the parties agree as
follows:
ARTICLE I
THE AMALGAMATION
1.1 The Amalgamation; Effective
Time . Subject to the provisions of this Agreement, and the
amalgamation agreement attached as Exhibit A (the “
Amalgamation Agreement ”), Validus, Amalgamation Sub
and IPC will cause (a) the Amalgamation Agreement to be
executed and delivered
and (b) an application for registration of
an amalgamated company (the “ Amalgamation Application
”) to be prepared, executed and delivered to the Registrar of
Companies in Bermuda (the “ Registrar ”) as
provided under Section 108 of the Companies Act on or prior to
the Closing Date and will cause the Amalgamation to become
effective pursuant to the Companies Act. The Amalgamation shall
become effective upon the issuance of a certificate of amalgamation
(the “ Certificate of Amalgamation ”) by the
Registrar or such other time as the Certificate of Amalgamation may
provide. The parties agree that they will request the Registrar
provide in the Certificate of Amalgamation that the Effective Time
will be the time when the Amalgamation Application is filed with
the Registrar or another time mutually agreed by the parties (the
“ Effective Time ”).
1.2 Closing . The closing of
the Amalgamation (the “ Closing ”) will take
place at 10:00 a.m. on the date (the “ Closing Date
”) that is the third business day after the satisfaction or
waiver (if such waiver is permitted and effective under applicable
Law (as defined in Section 3.5(a)) of the latest to be
satisfied or waived of the conditions set forth in ARTICLE VI
(excluding conditions that, by their terms, are to be satisfied on
the Closing Date), unless another time or date is agreed to in
writing by the parties. The Closing shall be held at the offices of
Cahill Gordon & Reindel LLP , 80
Pine Street, in New York, NY, unless another place is agreed to in
writing by the parties.
1.3 Effects of the
Amalgamation . As of the Effective Time, subject to the terms
and conditions of this Agreement and the Amalgamation Agreement,
IPC shall be amalgamated with Amalgamation Sub and the amalgamated
company (the “ Amalgamated Company ”) shall
continue after the Amalgamation. The parties acknowledge and agree
that for purposes of Bermuda Law ( a ) the Amalgamation
shall be effected so as to constitute an “amalgamation”
and ( b ) the Amalgamated Company shall be deemed to be
an “amalgamated company” in accordance with
Section 104 of the Companies Act. Under Section 109 of
the Companies Act, from and after the Effective Time: ( i
) the Amalgamation of IPC and Amalgamation Sub and their
continuance as one company shall become effective; ( ii
) the property of each of IPC and Amalgamation Sub shall
become the property of Amalgamated Company; ( iii
) Amalgamated Company shall continue to be liable for the
obligations and liabilities of each of IPC and Amalgamation Sub; (
iv ) any existing cause of action, claim or liability
to prosecution shall be unaffected; ( v ) a civil,
criminal or administrative action or proceeding pending by or
against IPC or Amalgamation Sub may be continued to be prosecuted
by or against Amalgamated Company; and ( vi ) a
conviction against, or ruling, order or judgment in favor of or
against, IPC or Amalgamation Sub may be enforced by or against
Amalgamated Company.
1.4 Amalgamated Company
Bye-laws . The bye-laws of the Amalgamated Company shall be the
bye-laws of the Amalgamation Sub.
1.5 [Reserved] .
1.6 Directors and Officers of the
Amalgamated Company .
(a) The parties hereto shall take
all actions necessary so that the board of directors of
Amalgamation Sub at the Effective Time shall, from and after the
Effective Time, be the directors of the Amalgamated Company until
the earlier of their resignation or removal or until their
respective successors are duly elected or appointed.
(b) The parties hereto shall take
all actions necessary so that the officers of Amalgamation Sub at
the Effective Time shall, from and after the Effective Time, be the
officers of the Amalgamated Company until the earlier of their
resignation or removal or until their respective successors are
duly elected or appointed.
2
1.7 Amalgamated Company Name
. IPC and Validus shall take all actions reasonably necessary so
that immediately after the Effective Time the name of the
Amalgamated Company shall be Validus Ltd.
ARTICLE II
CONVERSION OF IPC SECURITIES;
EXCHANGE OF CERTIFICATES
2.1 Effect on Share Capital .
Subject to the terms and conditions of this Agreement, at the
Effective Time, by virtue of the Amalgamation and without any
action on the part of the holder of any common shares in IPC, each
having a par value of $0.01 (each, an “ IPC Common
Share ”), as evidenced by way of entry in the register of
shareholders of IPC (the “ IPC Share Register ”)
or by share certificates registered in the name of a shareholder
and representing outstanding IPC Common Shares (each, an “
IPC Certificate ”):
(a) Conversion of IPC Common
Shares . Each IPC Common Share issued and outstanding
immediately prior to the Effective Time (other than Dissenting
Shares (as defined in Section 2.1(c)) shall be cancelled and
converted into the right to receive for each IPC Common Share
(i) 0.9727 (the “ Exchange Ratio ”) Validus
voting common shares, each having a par value of $0.175 (each, a
“ Validus Common Share ”) (the “ Per
Share Common Consideration ”), and (ii) $7.50 in
cash without interest (the “ Per Share Cash
Consideration ”) (the Per Share Common Consideration and
the Per Share Cash Consideration, together with any cash paid in
lieu of fractional shares in accordance with Section 2.2(e),
the “ Consideration ”). Upon such conversion,
each IPC Common Share shall be cancelled and each holder of IPC
Common Shares registered in the IPC Share Register or holding a
valid IPC Certificate immediately prior to the Effective Time shall
thereafter cease to have any rights with respect to such IPC Common
Shares except the right to receive the Consideration. The
Consideration shall be appropriately adjusted to reflect fully the
effect of any stock split, reverse stock split, stock dividend
(including any dividend or distribution of securities convertible
into Validus Common Shares or IPC Common Shares), reorganization,
recapitalization, reclassification or other like change with
respect to Validus Common Shares or IPC Common Shares having a
record date on or after the date hereof and prior to the Effective
Time.
(b) Cancellation of Validus-Owned
Securities . Notwithstanding anything in this Agreement to the
contrary, all IPC Common Shares that are owned by Validus or by any
subsidiary of Validus immediately prior to the Effective Time
shall, by virtue of the Amalgamation, and without any action on the
part of the holder thereof, automatically be cancelled and retired
without any conversion thereof and shall cease to exist, and no
payment shall be made in respect thereof.
(c) Shares of Dissenting
Holders . Notwithstanding anything in this Agreement to the
contrary, any issued and outstanding IPC Common Shares held by a
person who did not vote in favor of the Amalgamation and who
complies with all the provisions of the Companies Act concerning
the right of holders of IPC Common Shares to require appraisal of
their IPC Common Shares pursuant to Bermuda Law (any such holder, a
“ Dissenting Holder ,” and such IPC Common
Shares, “ Dissenting Shares ”) shall not be
converted into the right to receive the Consideration as described
in Section 2.1(a), but shall be cancelled and converted into
the right to receive the fair value thereof as appraised by the
Supreme Court of Bermuda under Section 106 of the Companies
Act. In the event that a Dissenting Holder fails to perfect,
effectively withdraws or otherwise waives any right to appraisal,
its IPC Common Shares shall be cancelled and converted as of the
Effective Time into the right to receive the Consideration for each
such Dissenting Share. IPC shall give Validus ( i
) prompt notice of ( A ) any written demands for
appraisal of Dissenting Shares or withdrawals of such demands
received by IPC and ( B ) to the extent that IPC has
actual knowledge, any applications to the Supreme Court of Bermuda
for
3
appraisal of the fair value of the
Dissenting Shares, and ( ii ) the opportunity to
participate with IPC in all negotiations and proceedings with
respect to any demands for appraisal under the Companies Act.
Neither IPC nor Validus shall, without the prior written consent of
the other party (not to be unreasonably withheld or delayed),
voluntarily make any payment with respect to, or settle, offer to
settle or otherwise negotiate, any such demands.
2.2 Exchange Procedures
.
(a) Exchange Agent . Prior to
the Effective Time, Validus shall designate an exchange and paying
agent reasonably acceptable to IPC (the “ Exchange
Agent ”) for the purpose of exchanging IPC Common Shares
outstanding immediately prior to the Effective Time. Prior to or at
the Effective Time, Validus shall deposit, or shall cause to be
deposited with the Exchange Agent in accordance with this ARTICLE
II, (i) certificates, or at Validus’ option, shares in
book entry form representing the Validus Common Shares to be
exchanged in the Amalgamation, (ii) a cash amount in
immediately available funds necessary for the Exchange Agent to
make payments of the aggregate Per Share Cash Consideration under
Section 2.1(a)(ii) (the “ Cash Portion ”),
(iii) cash in an amount sufficient to pay any cash payable in
lieu of fractional shares pursuant to Section 2.2(e) and
(iv) any dividends or distributions to which the shareholders
of IPC may be entitled pursuant to Section 2.2(c). Such
Consideration and cash so deposited are hereinafter referred to as
the “ Exchange Fund .” No interest shall be paid
or accrued for the benefit of holders of the IPC Certificates or
IPC Common Shares in the IPC Share Register on cash amounts payable
pursuant to this Section 2.2. The Exchange Agent shall invest
the Cash Portion as directed by Validus, provided that such
investments shall be in obligations of or guaranteed by the United
States of America, in commercial paper obligations rated A1 or P1
or better by Moody’s Investors Service, Inc. or
Standard & Poor’s, respectively, in certificates of
deposit, bank repurchase agreements or banker’s acceptances
of commercial banks with capital exceeding $1 billion, or in money
market funds having a rating in the highest investment category
granted by a recognized credit rating agency at the time of
investment. Any interest and other income resulting from such
investments shall be paid over promptly to Validus and any amounts
in excess of the amounts payable under Section 2.1(a)(ii)
shall be promptly returned to Validus. To the extent that there are
any losses with respect to any such investments, or the Cash
Portion diminishes for any reason below the level required for the
Exchange Agent to make prompt cash payment of the aggregate Per
Share Cash Consideration under Section 2.1(a)(ii), Validus
shall promptly replace or restore the cash in the Cash Portion so
as to ensure that the Cash Portion is at all times maintained at a
level sufficient for the Exchange Agent to pay the aggregate Per
Share Cash Consideration under Section 2.1(a)(ii).
(b) Exchange Procedures . As
promptly as practicable following the Effective Time, Validus or
the Amalgamated Company shall cause the Exchange Agent to mail, to
each shareholder of IPC, (i) a letter of transmittal (which
shall be in such form and have such other provisions as the parties
may reasonably specify) and (ii) where applicable,
instructions for use in effecting the surrender of IPC Certificates
or IPC Common Shares in the IPC Share Register, to the extent
available and in issue, in exchange for the Consideration. After
the Effective Time, upon surrender of title to the IPC Common
Shares previously held by a shareholder of IPC in accordance with
this Section 2.2, together with such letter of transmittal
duly executed if such shareholder holds IPC Certificates or IPC
Common Shares in the IPC Share Register, and such other documents
as the Exchange Agent may reasonably require, a holder of IPC
Common Shares shall be entitled to receive in exchange therefor
(i) a certificate or book-entry representing that number of
whole Validus Common Shares (rounded down) which such shareholder
has the right to receive in respect of the IPC Common Shares
formerly represented by such IPC Certificates or in the IPC Share
Register after taking into account all IPC Common Shares then held
by such shareholder, (ii) a cash amount in immediately
available funds (after giving effect to any required Tax
withholdings as provided in Section 2.2(i)) equal to
(1) the number of IPC Common Shares represented by such IPC
Certificate (or affidavit of loss in lieu thereof as provided in
Section 2.2(f)) or IPC Common Shares in the IPC Share Register
multiplied by (2) the Per Share Cash Consideration and
(iii) any cash in lieu of fractional shares that such
shareholder has the right to receive pursuant to Section
4
2.2(e), and any IPC Certificate surrendered in
respect thereof shall forthwith be marked as cancelled. In the
event of a transfer of ownership of IPC Common Shares that is not
registered in the transfer records of IPC, a certificate or
book-entry representing the proper number of Validus Common Shares
may be issued to a transferee if the IPC Certificate representing
such IPC Common Shares (if any) is presented to the Exchange Agent,
accompanied by all documents required to evidence and effect such
transfer and by evidence that any applicable stock transfer taxes
have been paid.
(c) Distributions with Respect to
Unexchanged Shares . No dividends or other distributions
declared or made with respect to Validus Common Shares with a
record date on or after the Effective Time shall be paid to any
shareholder of IPC holding any unsurrendered IPC Certificate or IPC
Common Shares in the IPC Share Register with respect to the Validus
Common Shares represented thereby, nor shall the cash payment in
lieu of fractional shares be paid to any such shareholder pursuant
to Section 2.2(e), until such shareholder shall surrender such
IPC Certificate in accordance with the procedures set forth in this
ARTICLE II. Following the surrender of any such IPC Certificate or
IPC Common Shares in the IPC Share Register in accordance with the
procedures set forth in this ARTICLE II, such shareholder shall be
entitled to receive, in addition to the consideration set forth in
Section 2.1(a), without interest, ( i ) at the
time of such surrender, the amount of any dividends or other
distributions with a record date on or after the Effective Time
theretofore paid (but withheld pursuant to the immediately
preceding sentence) with respect to such whole Validus Common
Shares which a shareholder of IPC holding such IPC Certificate is
entitled to receive hereunder, and ( ii ) at the
appropriate payment date, the amount of dividends or other
distributions with a record date after the Effective Time but prior
to surrender and a payment date subsequent to surrender payable
with respect to such whole Validus Common Shares which such
shareholder is entitled to receive hereunder.
(d) No Further Rights in IPC
Common Shares . All Consideration paid or issued upon the
surrender of title to IPC Common Shares in accordance with the
terms of this ARTICLE II (including any cash paid pursuant to this
ARTICLE II) shall be deemed to have been issued (and paid) in full
satisfaction of all rights pertaining to the shareholders of IPC,
in their capacity as shareholders of IPC prior to the Effective
Time. There shall be no further registration of transfers on the
share transfer books of the Amalgamated Company of the IPC Common
Shares which were outstanding immediately prior to the Effective
Time. If, after the Effective Time, IPC Certificates are presented
to Validus or to the Amalgamated Company or to the Exchange Agent
for any reason, they shall be marked as cancelled and exchanged in
accordance with this ARTICLE II, except as otherwise required by
Law.
(e) No Fractional Shares .
Notwithstanding anything in this Agreement to the contrary, no
fraction of a Validus Common Share will be issued in connection
with the Amalgamation, and in lieu thereof any shareholder of IPC
who would otherwise have been entitled to a fraction of a Validus
Common Share, shall be paid upon surrender of title to IPC Common
Shares for exchange (and after taking into account and aggregating
IPC Common Shares represented by all IPC Certificates surrendered
by such holder, or as set out in the IPC Share Register, as
applicable) cash in an amount (without interest) equal to the
product obtained by multiplying ( i ) the fractional
share interest to which such shareholder (after taking into account
and aggregating all IPC Common Shares represented by all IPC
Certificates surrendered by such shareholder or as set out in the
IPC Share Register, as applicable) would otherwise be entitled by (
ii ) the Average Validus Share Price (as defined in
Section 8.13(a)).
(f) Lost, Stolen or Destroyed
Certificates . In the event any IPC Certificates shall have
been lost, stolen or destroyed, the Exchange Agent shall issue in
exchange for such lost, stolen or destroyed certificates, upon the
making of an affidavit of that fact by the holder thereof, the
Consideration and any dividends or other distributions as may be
required pursuant to this ARTICLE II in respect of the IPC Common
Shares represented by such lost, stolen or destroyed certificates;
provided that Validus may, in its reasonable discretion and
as a condition precedent to the issuance thereof, require the owner
of such lost, stolen or destroyed certificates to deliver a bond in
such sum as it may reasonably direct as indemnity against any claim
that may be made against Validus or the Exchange Agent with respect
to the certificates alleged to have been lost, stolen or
destroyed.
5
(g) Termination of Exchange
Fund . Unless a longer period is prescribed by applicable Law
or Validus’ agreement with the Exchange Agent, any portion of
the Exchange Fund that remains undistributed to the shareholders of
IPC for six months after the Effective Time shall be delivered to
Validus, upon demand, and any shareholders of IPC who have not
theretofore complied with this ARTICLE II shall thereafter look
only to Validus for payment of their claim for the Consideration
and any dividends or distributions with respect to Validus Common
Shares.
(h) No Liability . To the
extent allowed under applicable Law, any Consideration and any
dividends or distributions with respect to Validus Common Shares
comprising the Consideration that remain undistributed to the
shareholders of IPC shall be delivered to and become the property
of Validus on the day immediately prior to the day that such
property is required to be delivered to any public official
pursuant to any applicable abandoned property, escheat or similar
Law. None of Validus, Amalgamation Sub, Amalgamated Company or the
Exchange Agent shall be liable to any shareholder of IPC for any
such property delivered to Validus or to a public official pursuant
to any applicable abandoned property, escheat or similar
Law.
(i) Withholding . The
Exchange Agent, Validus and the Amalgamated Company shall be
entitled to deduct and withhold from the consideration otherwise
payable pursuant to this Agreement to any shareholder of IPC such
amounts as it is required to deduct and withhold with respect to
the making of such payment under any provision of applicable Tax
Law. To the extent that amounts are so withheld by the Exchange
Agent, Validus or the Amalgamated Company, such withheld amounts
shall be treated for all purposes of this Agreement as having been
paid to the holder of the IPC Common Shares in respect of which
such deduction and withholding was made. The parties agree to
cooperate with each other for purposes of determining whether any
Taxes are required to be withheld with respect to the
Amalgamation.
2.3 IPC Equity Awards
.
(a) IPC Stock Options .
Subject to the terms and conditions of this Agreement, at the
Effective Time, by virtue of the transactions contemplated by this
Agreement and without any action on the part of any holder of any
outstanding option to purchase IPC Common Shares under any IPC
Share Plan (as defined in Section 3.2(a)), whether vested or
unvested, exercisable or unexercisable (each, an “ IPC
Share Option ”), each IPC Share Option that is
outstanding and unexercised immediately prior thereto shall cease
to represent a right to acquire IPC Common Shares and shall be
converted into an option (a “ New Option ”) to
purchase, on the same terms and conditions as were applicable under
the terms of the IPC Share Plan under which the IPC Share Option
was granted and the applicable award agreement thereunder (taking
into account any accelerated vesting thereunder), such number of
Validus Common Shares and at an exercise price per share determined
as follows:
(1) Number of Shares . The
number of Validus Common Shares subject to a New Option shall be
equal to the product of (A) the number of IPC Common Shares
subject to such IPC Share Option immediately prior to the Effective
Time and (B) the Option Exchange Ratio (as defined below), the
product being rounded, if necessary, to the nearest whole share;
and
(2) Exercise Price . The
exercise price per Validus Common Share purchasable upon exercise
of a New Option shall be equal to (A) the per share exercise
price of the IPC Share Option divided by (B) the Option
Exchange Ratio, the quotient being rounded, if necessary, to the
nearest cent.
The foregoing adjustments shall
(i) in the case of any IPC Share Option that is intended to be
an “incentive stock option” under Section 422 of
the Code, be determined in a manner consistent
6
with the requirements of Section 424(a) of
the Code and (ii) in the case of any IPC Share Option that is
not intended to be an “incentive stock option,” be
determined in a manner consistent with the requirements of
Section 409A of the Code.
As used herein, “ Option
Exchange Ratio ” means the sum of (i) the Exchange
Ratio plus (ii) the quotient of (A) the Per Share Cash
Consideration divided by (B) the closing price of a Validus
Common Share on the New York Stock Exchange on the last trading day
immediately preceding the Effective Time.
(b) IPC Other Awards .
Subject to the terms and conditions of this Agreement:
(1) at the Effective Time, by virtue
of the transactions contemplated by this Agreement and without any
action on the part of any holder of any outstanding right of any
kind, contingent or accrued, to acquire or receive IPC Common
Shares or share-based payments measured by the value of IPC Common
Shares, each outstanding award of any kind consisting of IPC Common
Shares or share-based payments measured by the value of IPC Common
Shares (including performance share units where the performance
period has ended prior to the Effective Time), in each case that
may be held, awarded, outstanding, payable or reserved for issuance
under any IPC Share Plan and any other IPC Benefit Plan (as defined
in Section 8.13(a)), but excluding IPC Share Options and IPC
performance share units for which the performance period expires on
or after the Effective Time (the “ IPC Non-Performance
Awards ”), shall be deemed to be converted into the right
to acquire or receive (x) a cash payment equal to the product
of (i) the number of IPC Common Shares subject to such IPC
Non-Performance Award immediately prior to the Effective Time and
(ii) the Per Share Cash Consideration and (y) share-based
payments measured by the value of (as the case may be) the number
of Validus Common Shares equal to the product (rounded, if
necessary, to the nearest whole number) of (i) the number of
IPC Common Shares subject to such IPC Non-Performance Award
immediately prior to the Effective Time and (ii) the Exchange
Ratio. Except as specifically provided above, following the
Effective Time, each such right shall otherwise be subject to the
same terms and conditions as were applicable to the rights under
the relevant IPC Share Plan or other IPC Benefit Plan and the
applicable award agreement thereunder (taking into account any
accelerated vesting thereunder) immediately prior to the Effective
Time; and
(2) at the Effective Time, by virtue
of the transactions contemplated by this Agreement and without any
action on the part of any holder of any IPC performance share unit,
each performance share unit granted under any IPC Share Plan or any
other IPC Benefit Plan (each a “ Performance Share
Unit ”) shall be deemed to be converted into the right to
acquire or receive (x) a cash payment equal to the product of
(i) the number of IPC Common Shares subject to such
Performance Share Unit immediately prior to the Effective Time and
(ii) the Per Share Cash Consideration and (y) the number
of Validus Common Shares equal to the product (rounded, if
necessary, to the nearest whole number) of (i) the number of
IPC Common Shares to which each Performance Share Unit relates
immediately prior to the Effective Time and (ii) the Exchange
Ratio. Except as specifically provided above and as set forth in
Section 2.3(b)(2) of the IPC Disclosure Letter, following the
Effective Time, each such right shall otherwise be subject to the
same terms and conditions as were applicable to the rights under
the relevant IPC Share Plan or any other IPC Benefit Plan and the
applicable award agreement thereunder (including by taking into
account any accelerated vesting thereunder) immediately prior to
the Effective Time. Performance Share Units and IPC Non-Performance
Awards shall be, collectively, referred to as the “ IPC
Other Awards .”
(c) Corporate Actions . Prior
to the Effective Time, IPC, or its board of directors or an
appropriate committee thereof, shall take all action necessary on
its part to give effect to the provisions of Sections 2.3(a) and
(b) and shall take such other actions reasonably requested by
Validus to give effect
7
to the foregoing (including obtaining the
consent of the holder of or amending the terms of any IPC Share
Options, IPC Other Awards or any IPC Share Plan). IPC shall take
all actions necessary to ensure that, from and after the Effective
Time, none of IPC, Validus, the Amalgamated Company or any of their
respective subsidiaries will be required to deliver IPC Common
Shares or other capital stock of IPC to any person pursuant to or
in settlement of IPC Share Options or IPC Other Awards at or after
the Effective Time.
(d) Registration . If
registration of any interests in the IPC Share Plans or any other
IPC Benefit Plan or the Validus Common Shares issuable thereunder
is required under the Securities Act, Validus shall file with the
SEC within five business days after the Effective Time a
registration statement on Form S-8 (or any successor or other
appropriate forms) with respect to such interests of Validus Common
Shares, and shall use its commercially reasonable efforts to
maintain the effectiveness of such registration statement (and
maintain the current status of the prospectus or the prospectuses
contained therein) for so long as the relevant IPC Share Plans or
other IPC Benefit Plans, as applicable, remain in effect and such
registration of interests therein or the Validus Common Shares
issuable thereunder continues to be required.
(e) Notice to Equity Award
Holders . As soon as practicable after the Effective Time,
Validus shall deliver to the holders of IPC Share Options and IPC
Other Awards appropriate notices setting forth such holders’
rights pursuant to any IPC Share Plan or IPC Benefit Plan and
agreements evidencing such IPC Share Options and IPC Other Awards
and stating that the IPC Share Plans or IPC Benefit Plans and such
IPC Share Options and IPC Other Awards and agreements have been
assumed by Validus and shall continue in effect on the same terms
and conditions (subject to the adjustments required by this
Section 2.3 after giving effect to the Amalgamation and the
terms of the IPC Share Plans or IPC Benefit Plans).
ARTICLE III
REPRESENTATIONS AND
WARRANTIES
Except as ( i ) set
forth in the correspondingly identified subsection of the
disclosure letter delivered by Validus to IPC simultaneously with
the execution of this Agreement by Validus (the “ Validus
Disclosure Letter ”) or the disclosure letter delivered
by IPC to Validus simultaneously with the execution of this
Agreement by IPC (the “ IPC Disclosure Letter ”
and each of the Validus Disclosure Letter and the IPC Disclosure
Letter, a “ Disclosure Letter ”), as the case
may be, or ( ii ) disclosed in the relevant
party’s SEC Documents filed with the SEC on or after
January 1, 2008, and prior to the date of this Agreement
(excluding any disclosures set forth in any risk factor section or
forward-looking statements contained therein), IPC hereby
represents and warrants to Validus, and Validus (and Amalgamation
Sub with respect to Sections 3.1(a), 3.1(c), 3.3 and 3.9(c)) hereby
represents and warrants to IPC, to the extent applicable, in each
case with respect to itself and its subsidiaries, as
follows:
3.1 Organization, Standing and
Power .
(a) Each of it and its subsidiaries
is a company or other legal entity duly organized and validly
existing and in good standing (with respect to jurisdictions which
recognize such concept) under the Laws of its jurisdiction of
incorporation or organization, has all requisite power and
authority to own, lease and operate its properties and to carry on
its business as now being conducted, and is duly qualified to do
business in each jurisdiction in which the nature of its business
or the ownership or leasing of its properties makes such
qualification necessary, except where the failure to be so
qualified has not had and would not be reasonably expected to have,
individually or in the aggregate, a Material Adverse
Effect.
8
(b) The copies of its memorandum of
association and bye-laws incorporated by reference in its Form 10-K
for the year ended December 31, 2008, are true, complete and
correct copies of such documents, are in full force and effect and
have not been amended or otherwise modified, except as they may be
or have been amended or otherwise modified pursuant to the IPC
Bye-Law Amendment.
(c) Validus and Amalgamation Sub
represent to IPC that: ( i ) true and complete copies
of the memorandum of association and bye-laws of Amalgamation Sub,
each as in effect as of the date of this Agreement, have previously
been made available to IPC, ( ii ) Amalgamation Sub was
formed by Validus solely for the purpose of effecting the
Amalgamation and the other transactions contemplated by this
Agreement, and ( iii ) Amalgamation Sub has not
conducted any business prior to the date hereof and has no, and
immediately prior to the Effective Time will have no, assets,
liabilities or obligations of any nature other than those incident
to its formation and pursuant to this Agreement.
3.2 Capital Structure
.
(a) Its authorized share capital and
outstanding common shares as of the date set forth in the
corresponding section of its Disclosure Letter, including any
shares reserved for issuance upon the exercise or payment of
outstanding warrants and outstanding stock options or other equity
related awards (such stock option and other equity-based award
plans, agreements and programs, collectively, in the case of
Validus, the “ Validus Share Plans ” and, in the
case of IPC, the “ IPC Share Plans ”), is
described in the corresponding section of its Disclosure Letter. In
the case of Validus, none of its Common Shares are held by it or by
its subsidiaries. In the case of IPC, its Common Shares that are
held by it and its subsidiaries are described in the corresponding
section of its Disclosure Letter. All of its outstanding Common
Shares have been duly authorized and validly issued and are fully
paid and nonassessable and not subject to preemptive rights.
Section 3.2(a) of its Disclosure Letter sets forth a list of
all warrants, options, restricted stock, restricted stock units or
other equity awards outstanding as of the date hereof.
(b) From January 1, 2009, to
the date hereof, it has not issued or permitted to be issued any
common shares, share appreciation rights or securities exercisable
or exchangeable for or convertible into shares in its or any of its
subsidiaries’ share capital.
(c) It or one of its wholly-owned
subsidiaries owns all of the issued and outstanding shares in the
share capital of its subsidiaries, beneficially and of record, and
all such shares are fully paid and nonassessable, are not subject
to preemptive rights and are free and clear of any claim, lien or
encumbrance.
(d) No bonds, debentures, notes or
other indebtedness having the right to vote (or which are
convertible into or exercisable for securities having the right to
vote) on any matters on which shareholders may vote (“
Voting Debt ”) of it or any of its subsidiaries are
issued or outstanding.
(e) Except for options or other
equity-based awards issued or to be issued under the Validus Share
Plans (in the case of Validus) or the IPC Share Plans (in the case
of IPC), there are no options, warrants, calls, convertible or
exchangeable securities, rights, commitments or agreements of any
character to which it or any of its subsidiaries is a party or by
which it or any such subsidiary is bound ( i
) obligating it or any of its subsidiaries to issue, deliver
or sell, or cause to be issued, delivered or sold, additional
shares of the share capital or any Voting Debt or other equity
rights of it or any of its subsidiaries, ( ii
) obligating it or any of its subsidiaries to grant, extend or
enter into any such option, warrant, call, convertible or
exchangeable security, right, commitment or agreement or (
iii ) that provide the economic equivalent of an equity
ownership interest in it or any of its subsidiaries.
(f) None of it or any of its
subsidiaries is a party to any member or shareholder agreement,
voting trust agreement or registration rights agreement relating to
any equity securities of it or
9
any of its subsidiaries or any other agreement
relating to disposition, voting or dividends with respect to any
equity securities of it or any of its subsidiaries. There are no
outstanding contractual obligations of it or any of its
subsidiaries to repurchase, redeem or otherwise acquire any shares
in the share capital of it or any of its subsidiaries.
(g) Since January 1, 2009,
through the date of this Agreement, it has not declared, set aside,
made or paid to its shareholders dividends or other distributions
on the outstanding shares in its share capital.
(h) It has not waived any voting
cut-back, transfer restrictions or similar provisions of its or its
subsidiaries’ bye-laws with respect to any of its or their
shareholders, except for such waivers set forth in its
bye-laws.
3.3 Authority;
Non-Contravention .
(a) It has all requisite corporate
power and authority to enter into this Agreement and, subject to
obtaining the Required Validus Vote (as defined in
Section 3.10(a)) (in the case of Validus) or the Required IPC
Vote (as defined in Section 3.10(b)) (in the case of IPC), to
consummate the transactions contemplated hereby. The execution and
delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly authorized by all necessary
corporate action on its part and no other corporate proceedings on
its part are necessary to authorize this Agreement and consummate
the transactions contemplated hereby, subject to the Required
Validus Vote (in the case of Validus) or the Required IPC Vote (in
the case of IPC). This Agreement has been duly executed and
delivered by it and (assuming the due authorization, execution and
delivery by the other parties hereto) constitutes a valid and
binding obligation of it, enforceable against it in accordance with
its terms, except to the extent enforcement is limited by
bankruptcy, insolvency, fraudulent transfer, reorganization,
moratorium and similar Laws of general applicability relating to or
affecting creditors’ rights and by general equitable
principles.
(b) Neither the execution and
delivery of this Agreement by it nor the consummation by it of the
transactions contemplated hereby, nor compliance by it with any of
the terms or provisions hereof, will ( i ) violate any
provision of the memorandum of association or bye-laws of it (as
they may be or have been modified, in the case of IPC, pursuant to
the IPC Bye-Law Amendment) or the memorandum of association,
bye-laws or equivalent organizational documents of any of its
subsidiaries or ( ii ) assuming that the consents,
approvals, orders, authorizations, registrations, declarations and
filings referred to in Section 3.3(c) are duly obtained or
made, ( A ) violate any Law applicable to it or any of
its subsidiaries or any of their respective properties or assets or
( B ) violate, conflict with, result in a breach of any
provision of or the loss of any benefit under, constitute a default
(or an event which, with notice or lapse of time, or both, would
constitute a default) under, result in the cancellation,
suspension, non-renewal or termination of or a right of termination
or cancellation under, accelerate the performance required by, or
result in the creation of any lien, pledge, security interest,
charge or other encumbrance upon ( 1 ) any Permit (as
defined in Section 3.5(a)) or ( 2 ) any of the
respective properties or assets of it or any of its subsidiaries
under, any of the terms, conditions or provisions of any loan or
credit agreement, note, mortgage, indenture, lease, Validus Benefit
Plan (as defined in Section 8.13(a)) (in the case of Validus)
or IPC Benefit Plan (as defined in Section 8.13(a)) (in the
case of IPC) or other agreement, obligation or instrument to which
it or any of its subsidiaries is a party, or by which they or any
of their respective properties or assets may be bound or affected,
except (with respect to clause (ii)) for such violations, conflicts
or breaches that have not had and would not be reasonably expected
to have, individually or in the aggregate, a Material Adverse
Effect.
(c) No consent, approval, order or
authorization of, or registration, declaration or filing with, any
court, administrative agency or commission or other governmental
authority, body, agency, official or instrumentality, domestic or
foreign, or self-regulatory organization or other
similar
10
non-governmental regulatory body (each, a
“ Governmental Entity ”), is required to be made
or obtained by it or any of its subsidiaries in connection with the
execution and delivery of this Agreement by it or the consummation
by it of the transactions contemplated hereby, except for (
i ) the filing of the Amalgamation Application and
related attachments with the Registrar, ( ii ) the
written notification to the Bermuda Monetary Authority regarding
Validus’ acquisition of the IPC Common Shares, ( iii
) such other applications, filings, authorizations, orders and
approvals as may be required under applicable Laws (including all
applicable Insurance Laws) of any jurisdiction and any approvals
thereof, which are set forth in Section 3.3(c) of its
Disclosure Letter, ( iv ) the filing with the SEC of
such registrations, prospectuses, reports and other materials as
may be required in connection with this Agreement and the
transactions contemplated hereby, including the Joint Proxy
Statement/ Prospectus (as defined in Section 5.1(a)), and the
obtaining from the SEC of such orders as may be required in
connection therewith, ( v ) compliance with any
applicable requirements of NASDAQ or the New York Stock Exchange
(the “ NYSE ”), as applicable, ( vi
) in the case of Validus, such filings and approvals as are
required to be made or obtained under the securities or “Blue
Sky” Laws of various jurisdictions in connection with the
issuance of the Validus Common Shares pursuant to this Agreement,
and ( vii ) for any other such consent, approval, order
or authorization of, or registration, declaration or filings, the
failure of which to obtain or make would not be reasonably expected
to have, individually or in the aggregate, a Material Adverse
Effect.
3.4 SEC Documents; Regulatory
Reports; Undisclosed Liabilities .
(a) It and its subsidiaries have
timely filed all required reports, schedules, registration
statements and other documents with the SEC since January 1,
2008 (the “ SEC Documents ”). As of their
respective dates of filing with the SEC (or, if amended or
superseded by a filing prior to the date hereof, as of the date of
such filing), the SEC Documents complied in all material respects
with the requirements of the Securities Act of 1933, as amended
(the “ Securities Act ”), or the Securities
Exchange Act of 1934, as amended (the “ Exchange Act
”), as the case may be, and the rules and regulations of the
SEC thereunder applicable to such SEC Documents, and none of its or
its subsidiaries’ SEC Documents when filed contained any
untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they
were made, not misleading. The financial statements of it and its
subsidiaries included in its SEC Documents complied, as of their
respective dates of filing with the SEC (or, if amended or
superseded by a filing prior to the date hereof, as of the date of
such filing), with all applicable accounting requirements and with
the published rules and regulations of the SEC with respect
thereto, have been prepared in accordance with GAAP applied on a
consistent basis during the periods involved (except as may be
disclosed therein) and fairly present in all material respects the
consolidated financial position of it and its consolidated
subsidiaries and the consolidated results of operations, changes in
shareholders’ equity and cash flows of such companies as of
the dates and for the periods shown. As of the date hereof, there
are no outstanding written comments from the SEC with respect to
its SEC Documents.
(b) Except for ( i
) those liabilities that are reflected or reserved for in its
consolidated financial statements included in its Annual Report on
Form 10-K for the year ended December 31, 2008, as filed with
the SEC prior to the date of this Agreement, ( ii
) liabilities and obligations incurred pursuant to this
Agreement, (iii) liabilities incurred since December 31,
2008, ( 1 ) in the ordinary course of business
(including claims and any related litigation or arbitration arising
in the ordinary course of business under Policies (as defined in
Section 3.12(g))) or ( 2 ) pursuant to any
Reinsurance Agreements (as defined in Section 3.12(e)) issued
or assumed, as the case may be, by one of its Insurance Entities
(as defined in Section 3.12(a)) for which adequate claims
reserves have been established, and (iv) liabilities which
have not had and would not be reasonably expected to have,
individually or in the aggregate, a Material Adverse Effect, it and
its subsidiaries do not have, and since December 31, 2008, it
and its subsidiaries have not incurred, any liabilities or
obligations of any nature whatsoever (whether accrued, absolute,
contingent or otherwise and whether or not required to be reflected
in its financial statements in accordance with GAAP).
11
3.5 Compliance with Applicable
Laws and Reporting Requirements . Except as has not had and
would not be reasonably expected to have, individually or in the
aggregate, a Material Adverse Effect:
(a) It and its subsidiaries hold in
full force and effect all permits, certifications, registrations,
permissions, consents, franchises, concessions, licenses,
variances, exemptions, orders, approvals and authorizations of all
Governmental Entities necessary for the ownership and conduct of
the business of it and its subsidiaries (including any insurance
licenses or permissions from insurance regulatory authorities) in
each of the jurisdictions in which it or its subsidiaries currently
conduct or operate its business (the “ Permits
”), and it and its subsidiaries are in compliance with the
terms and requirements of its Permits and any applicable law,
statute, ordinance, common law, arbitration award, or any rule,
regulation, judgment, order, writ, injunction, decree, agency
requirement or published interpretation of any Governmental Entity,
including all relevant bye-laws and regulations of the Council and
Society of Lloyd’s incorporated under the Lloyd’s Act
of 1871 to 1982 of England and Wales (“ Lloyd’s
”) in each of the jurisdictions in which it or its
subsidiaries currently conduct business or operate (collectively
“ Laws ”). The businesses of it and its
subsidiaries have not been, and are not being, conducted in
violation of any applicable Laws (including the USA PATRIOT Act of
2001, as amended, the Foreign Corrupt Practices Act, 15 U.S.C.
§ 78dd 1 et seq ., as amended (or any other similar
applicable foreign, federal, or state legal requirement),
anti-money laundering laws, anti-terrorism laws, all applicable
requirements relating to the sale, issuance, marketing, advertising
and administration of insurance products (including licensing and
appointments) and all Laws regulating the business and products of
insurance and all applicable orders and directives of insurance
regulatory authorities (the “ Insurance Laws ”)
and all applicable laws or other legal requirements relating to the
retention of e-mail and other information). It and its subsidiaries
have not received, at any time since January 1, 2007, any
written notice or communication from any Governmental Entity
regarding any actual, alleged, or potential violation of, or a
failure to comply with, any Laws or the terms and requirements of
any Permit or any actual or potential revocation, withdrawal,
suspension, cancellation, modification, or termination of any
Permit. All applications required to have been filed for the
renewal of each Permit or other filings required to be made with
respect to each Permit held by it or its subsidiaries have been
duly filed on a timely basis with the appropriate Governmental
Entity.
(b) It has established and maintains
disclosure controls and procedures (as defined in Rule 13a-15 under
the Exchange Act). Such disclosure controls and procedures are
designed to ensure that material information relating to it,
including its consolidated subsidiaries, is made known to its
principal executive officer and its principal financial officer by
others within those entities, particularly during the periods in
which the periodic reports required under the Exchange Act are
being prepared. Such disclosure controls and procedures are
effective in timely alerting its principal executive officer and
principal financial officer to material information required to be
included in its periodic reports under the Exchange Act and ensure
that the information required to be disclosed in its SEC Documents
is recorded, processed, summarized and reported within the time
periods specified by the SEC’s rules and forms. It and its
subsidiaries maintain a system of internal controls over financial
reporting sufficient to provide reasonable assurances regarding the
reliability of financial reporting and the preparation of financial
statements in accordance with GAAP. The records, systems, controls,
data and information of it and its subsidiaries are recorded,
stored, maintained and operated under means (including any
electronic, mechanical or photographic process, whether
computerized or not) that are under the exclusive ownership and
direct control of it or its subsidiaries or accountants (including
all means of access thereto and therefrom) and are held or
maintained in such places as may be required under all applicable
Laws (including Insurance Laws). It has disclosed, based on its
most recent evaluation of internal controls prior to the date
hereof, to its auditors and audit committee (i) any
significant deficiencies and material weaknesses in the design or
operation of internal controls which are
12
reasonably likely to adversely
affect its ability to record, process, summarize and report
financial information and (ii) any fraud that involves
management or other employees who have a significant role in
internal controls.
(c) There are no outstanding loans
or other extensions of credit made by it or any of its subsidiaries
to any of its executive officers (as defined in Rule 3b-7 under the
Exchange Act) or directors.
(d) Since January 1, 2007, in
the case of IPC, it has complied with the applicable listing and
corporate governance rules and regulations of NASDAQ . Since
July 24, 2007, in the case of Validus, it has complied with
the applicable listing and corporate governance rules and
regulations of the NYSE.
(e) Neither it nor any of its
subsidiaries is a party to, or has any commitment to become a party
to, any joint venture, off-balance sheet partnership or any similar
contract (including any contract relating to any transaction or
relationship between or among it and any of its subsidiaries, on
the one hand, and any unconsolidated affiliate, including any
structured finance, special purpose or limited purpose entity, on
the other hand, or any “off-balance sheet arrangement”
(as defined in Item 303(a) of Regulation S-K of the SEC)),
where the result, purpose or intended effect of such contract is to
avoid disclosure of any material transaction involving, or material
liabilities of, it or any of its subsidiaries in the SEC
Documents.
3.6 Legal and Arbitration
Proceedings and Investigations . Except for litigation or
arbitration arising in the ordinary course of business from claims
under Policies or Reinsurance Agreements issued or assumed, as the
case may be, by one of its Insurance Entities for which adequate
claims reserves have been established, there are no claims, suits,
actions, proceedings, arbitrations or other proceedings whether
judicial, arbitral or administrative, civil or criminal (“
Legal Proceedings ”) pending or, to its knowledge,
threatened, against it or any of its subsidiaries, any present or
former officer, director or employee thereof in his or her capacity
as such or any person for whom it or its subsidiaries may be liable
or any of their respective properties, that, if determined or
resolved adversely against it, would be reasonably expected to
have, individually or in the aggregate, a Material Adverse Effect,
nor are there any writs, judgments, decrees, injunctions, rules or
orders of any Governmental Entity or arbitrator binding upon it or
any of its subsidiaries or any of their respective assets or
properties that would be reasonably expected to have, individually
or in the aggregate, a Material Adverse Effect. To its knowledge,
since January 1, 2007, there have been no formal or informal
SEC inquiries, investigations or subpoenas, other Governmental
Entity inquiries or investigations or internal investigations or
material whistle-blower complaints pending or otherwise threatened
involving it or its subsidiaries or any current or former officer
or director thereof in his or her capacity as such, other than, in
each case, those that if determined or resolved adversely against
it would not be reasonably expected to have, individually or in the
aggregate, a Material Adverse Effect.
3.7 Taxes .
(a) All material Tax Returns (as
defined in Section 8.13(a)) required by applicable Law to be
filed with any Taxing Authority (as defined in
Section 8.13(a)) by, or on behalf of, it or any of its
subsidiaries have been filed when due (taking into account
extensions of time to file) in accordance with all applicable Laws,
and all such Tax Returns are true, correct and complete in all
material respects. All such Tax Returns have been examined by the
appropriate Taxing Authority or the period for assessment of the
Taxes (as defined in Section 8.13(a)) in respect of which such
Tax Returns were required to be filed has expired.
(b) There are no liens for any Taxes
upon the assets of it or any of its subsidiaries, other than (
i ) statutory liens for Taxes not yet due and payable
or ( ii ) liens which are being contested in good faith
by appropriate proceedings, for which adequate reserves have been
established on its financial statements in accordance with GAAP and
Applicable SAP.
13
(c) It and each of its subsidiaries
have paid or have withheld and remitted to the appropriate Taxing
Authority all material Taxes due and payable, and have established
in accordance with GAAP and Applicable SAP an adequate accrual for
all material Taxes not yet due and payable.
(d) There is no claim, audit,
action, suit, proceeding, examination or investigation now pending
or, to its knowledge, threatened against or with respect to it or
any of its subsidiaries in respect of any Tax or Tax Asset (as
defined in Section 8.13(a)), and any deficiencies asserted or
assessments made as a result of any claim, audit, suit, proceeding,
examination or investigation have been paid in full.
(e) It and each of its subsidiaries
have withheld all material amounts required to have been withheld
by them in connection with amounts paid or owed to (or any benefits
or property provided to) any employee, independent contractor,
creditor, shareholder or any other third party; such withheld
amounts were either duly paid to the appropriate Taxing Authority
or set aside in accounts for such purpose. It and each of its
subsidiaries have reported such withheld amounts to the appropriate
Taxing Authority and to each such employee, independent contractor,
creditor, shareholder or any other third party, as required under
Law.
(f) Neither it nor any of its
subsidiaries is a party to a Tax allocation, sharing, indemnity or
similar agreement (other than indemnities included in ordinary
course employment contracts or leases) that will require any
payment by it or any of its subsidiaries of any Tax of another
person after the Closing Date.
(g) Neither it nor any of its
subsidiaries has entered into a “reportable
transaction” within the meaning of Treasury Regulations
Section 1.6011-4, and neither it nor any of its subsidiaries
has been a “material advisor” to any such transaction
within the meaning of Section 6111 of the Code.
(h) Neither it nor any of its
subsidiaries ( i ) has filed any extension of time
within which to file any Tax Returns that have not been filed, (
ii ) has entered into any agreement or other
arrangement waiving or extending the statute of limitations or the
period of assessment or collection of any material Taxes, (
iii ) has granted any power of attorney that is in
force with respect to any matters relating to any material Taxes, (
iv ) has applied for a ruling from a Taxing Authority
relating to any material Taxes that has not been granted or has
proposed to enter into an agreement with a Taxing Authority that is
pending, or ( v ) has entered into any “closing
agreement” as described in Section 7121 of the Code (or
any similar provision of state, local or foreign Tax Law) or been
issued any private letter rulings, technical advance memoranda or
similar agreement or rulings by any Taxing Authority.
(i) None of its subsidiaries is now
or has ever been a United States real property holding corporation
within the meaning of Section 897(c)(2) of the
Code.
(j) Neither it nor any of its
subsidiaries has agreed to, requested, or is required to include
any adjustment under Section 481 of the Code (or any
corresponding provision of applicable Law) by reason of a change in
accounting method or otherwise.
(k) Neither it nor any of its
subsidiaries has elected to be a pass-through entity for U.S.
federal income tax purposes.
(l) Neither it nor any of its
subsidiaries organized outside the United States has ever been
engaged in a trade or business in the United States within the
meaning of Section 864(b) of the Code or has ever had a
permanent establishment in the United States within the meaning of
the tax treaty between the United States and Bermuda.
14
(m) Neither it nor any of its
subsidiaries has ever been a member of an affiliated, combined,
consolidated or unitary Tax group for purposes of filing any Tax
Return.
(n) Neither it nor any of its
subsidiaries has been a distributing corporation or a controlled
corporation in a transaction intended to be governed by
Section 355 of the Code.
(o) It and each of its subsidiaries
currently satisfies (assuming the relevant taxable year ended on
the date this representation is being given), and expects to
satisfy with respect to the taxable year in which the Closing Date
falls, either or both of the exceptions described in Sections
953(c)(3)(A) and (B) of the Code so that none of its
“United States shareholders” (within the meaning of
Section 953(c) of the Code) will be required to include in
income any of its or its subsidiaries’ “related person
insurance income” (within the meaning of
Section 953(c)(2) of the Code) by operation of Sections 951(a)
and 953(c)(5) of the Code.
(p) Neither it nor any of its
subsidiaries has received any notice or inquiry from any
Governmental Entity outside of Bermuda to the effect that any of it
or its subsidiaries that are domiciled or formed in Bermuda are
subject to any Tax other than excise taxes or any Tax assessed by
Bermuda.
(q) Other than as disclosed with
respect to Section 3.7(l), Section 3.7(p) or this
Section 3.7(q), it and each of its subsidiaries has never been
subject to net basis taxation in any country, or been tax resident
or tax domiciled in any country, other than the country in which it
and each of its subsidiaries, respectively, is
organized.
(r) Neither it nor any of its
subsidiaries organized outside the United Kingdom has or has ever
had a permanent establishment in the United Kingdom for United
Kingdom Tax purposes.
(s) No material transaction or
arrangement involving it or any of its subsidiaries has taken place
or is in existence which is such that it has resulted, or is
reasonably likely to result, in the income, profits or gains of it
or of any subsidiary being adjusted for Tax purposes in any
jurisdiction in accordance with applicable transfer pricing or thin
capitalization laws.
(t) As of the date of this
Agreement, neither it nor any of its subsidiaries has taken or
agreed to take any action, or is aware of any agreement, plan or
circumstance, that, to its knowledge, would reasonably be expected
to prevent the Amalgamation from constituting a
“reorganization,” within the meaning of
Section 368(a) of the Code.
3.8 Absence of Certain Changes or
Events . Since January 1, 2009, (i) there has not
been any event, change, circumstance, state of facts or effect,
alone or in combination, that has had or would be reasonably likely
to have, individually or in the aggregate, a Material Adverse
Effect, and (ii) neither it nor any of its subsidiaries has
taken any action or failed to take any action that would have
resulted in a breach in any material respect of Section 4.1
had such section been in effect since January 1, 2009, except,
with respect to IPC, for any action taken or failed to be taken in
connection with or in furtherance of the Max Agreement that has
been publicly disclosed by IPC in a filing with the SEC made prior
to 5:30 p.m., New York City time, at least one business day prior
to the date of this Agreement.
3.9 Board Approval
.
(a) In the case of IPC, the board of
directors of IPC, by resolutions duly adopted by unanimous vote at
a meeting duly called and held, has ( i ) determined
that the Consideration and the Exchange Ratio constitutes fair
value for each IPC Common Share in accordance with the Companies
Act and deemed it fair to, advisable to and in the best interests
of IPC to enter into this Agreement and to consummate, the
Amalgamation and the other transactions contemplated hereby, (
ii ) adopted this Agreement and the Amalgamation
Agreement and authorized and approved the Amalgamation and
the
15
other transactions contemplated by this
Agreement, (iii) recommended that the shareholders of IPC vote
in favor of matters constituting the Required IPC Vote (as defined
in Section 3.10(b)) (the “ IPC Recommendation
”) and (iv) determined that the amendments to
IPC’s bye-laws attached as Exhibit B (the “
IPC Bye-Law Amendment ”) are advisable to and in the
best interests of IPC, and directed that such matters be submitted
for consideration by IPC shareholders at the IPC Shareholders
Meeting (as defined in Section 5.1(c)).
(b) In the case of Validus, the
board of directors of Validus, by resolutions duly adopted by
unanimous vote at a meeting duly called and held, has ( i
) deemed it fair to, advisable and in the best interests of
Validus to enter into this Agreement and to consummate the Share
Issuance and the other transactions contemplated hereby, (
ii ) adopted this Agreement and authorized and approved
the Share Issuance, and ( iii ) recommended that the
shareholders of Validus vote in favor of the matters constituting
the Required Validus Vote (as defined in Section 3.10(a)) (the
“ Validus Recommendation ”) and directed that
such matters be submitted for consideration by Validus shareholders
at the Validus Shareholders Meeting (as defined in
Section 5.1(b)).
(c) In the case of Validus, the
board of directors of Amalgamation Sub, by unanimous written
consent without a meeting, has ( i ) determined that
this Agreement and the Amalgamation are advisable and in the best
interests of Amalgamation Sub and its sole shareholder, ( ii
) adopted this Agreement and authorized and approved the
Amalgamation and ( iii ) recommended that the sole
shareholder of Amalgamation Sub approve such matters. The sole
shareholder of Amalgamation Sub has approved this Agreement, the
Amalgamation and the other transactions contemplated
hereby.
3.10 Vote Required
.
(a) In the case of Validus, the
affirmative vote of a majority of the votes cast at a meeting of
the shareholders of Validus at which a quorum is present in
accordance with the bye-laws of Validus to approve the Share
Issuance (the “ Required Validus Vote ”) is the
only vote of the holders of any class or series of Validus capital
stock necessary to consummate the transactions contemplated
hereby.
(b) In the case of IPC, the
affirmative vote of a majority of the votes cast at a meeting of
the shareholders of IPC at which a quorum is present in accordance
with the bye-laws of IPC, in each case, to approve the IPC Bye-Law
Amendment and, assuming approval of the IPC Bye-Law Amendment,
adopt this Agreement and approve the Amalgamation ( provided
, however , if the IPC Bye-Law Amendment is not approved,
the affirmative vote of three-fourths of the votes cast at such
meeting shall be required to adopt this Agreement and approve the
Amalgamation) (the “ Required IPC Vote ” and,
together with the Required Validus Vote, the “ Required
Shareholder Votes ”) is the only vote of the holders of
any class or series of IPC share capital necessary to approve this
Agreement and consummate the transactions contemplated hereby
(including the Amalgamation).
3.11 Agreements with
Regulators . Except as required by Insurance Laws of general
applicability and the insurance licenses maintained by its
Insurance Entities or as does not have and would not be reasonably
expected to have, individually or in the aggregate, a Material
Adverse Effect, there are no written agreements, memoranda of
understanding, commitment letters or similar undertakings binding
on it or any of its subsidiaries or to which it or any of its
subsidiaries is a party, on one hand, and any Governmental Entity
is a party or addressee, on the other hand, or any orders or
directives by, or supervisory letters or cease-and-desist orders
from, any Governmental Entity, nor has it nor any of its
subsidiaries adopted any board resolution at the request of any
Governmental Entity, in each case specifically with respect to it
or any of its subsidiaries, which ( a ) limit the
ability of it or any of its Insurance Entities to issue Policies or
enter into Reinsurance Agreements; ( b ) require any
divestiture of any investment of any subsidiary; ( c
) in any manner relate to the ability of any of its
subsidiaries to pay dividends; ( d ) require any
investment of its Insurance Entities to be treated as
non-admitted
16
assets (or the local equivalent) or ( e
) otherwise restrict the conduct of business of it or any
subsidiary, nor has it been advised by any Governmental Entity that
it is contemplating any such undertakings.
3.12 Insurance Matters
.
(a) Each of its subsidiaries which
by virtue of its operations and activities is required to be
licensed as an insurance company, insurance intermediary,
Lloyd’s corporate member or Lloyd’s managing agent
(collectively, the “ Insurance Entities ”) is
listed in Section 3.12 of its Disclosure Letter, together with
the jurisdiction of domicile thereof. None of its Insurance
Entities is commercially domiciled in any other jurisdiction or is
otherwise treated as domiciled in a jurisdiction other than that of
its incorporation. It conducts all of its insurance operations that
are required to be conducted through a licensed insurance company
or insurance intermediary, through its Insurance Entities, each of
which is duly licensed or authorized as an insurance company,
and/or, where applicable, a reinsurer, insurance intermediary,
Lloyd’s corporate member or Lloyd’s managing agent, in
its jurisdiction of incorporation and each other jurisdiction where
it is required to be so licensed or authorized and is duly licensed
or authorized in each such jurisdiction for each line of business
written therein, except where the failure to so conduct its
insurance operations or the failure of its Insurance Entities to be
so licensed or authorized has not had and would not be reasonably
expected to have, individually or in the aggregate, a Material
Adverse Effect.
(b) Since January 1, 2007, each
of its Insurance Entities has timely filed or submitted all annual
and, to the extent applicable Law requires, quarterly and other
periodic statements, together with all exhibits, interrogatories,
notes, schedules and any actuarial opinions, affirmations or
certifications or other supporting documents in connection
therewith, required to be filed with or submitted to the
appropriate insurance regulatory authorities of the jurisdiction in
which it is domiciled or commercially domiciled on forms prescribed
or permitted by such authority (as filed through the date hereof
and thereafter, collectively, the “ Statutory
Statements ”), except, in each case, as has been cured or
resolved to the satisfaction of such insurance regulatory authority
without imposition of any material penalty or as would not,
individually or in the aggregate, be reasonably expected to have a
Material Adverse Effect.
It has delivered or made available
to the other parties, to the extent permitted by applicable Laws,
(i) true and complete copies of all annual Statutory
Statements filed with Governmental Entities for each of its
Insurance Entities for the periods beginning January 1, 2007
through the date hereof and, once duly and timely filed,
thereafter, and the quarterly Statutory Statements for each of its
Insurance Entities for the quarterly periods ended
September 30, 2008, through the date hereof and, once duly and
timely filed, thereafter, each in the form (including exhibits,
annexes and any amendments thereto) filed with the applicable
insurance regulatory authority and (ii) true and complete
copies of all examination reports (and has notified the other party
of any pending examinations) of any insurance regulatory
authorities received by it on or after January 1, 2007 through
the date hereof relating to its Insurance Entities. Financial
statements included in its Statutory Statements were prepared in
conformity with Applicable SAP, consistently applied for the
periods covered thereby, were prepared in accordance with the books
and records of the applicable Insurance Entity, and present fairly
in all material respects the statutory financial position of the
relevant Insurance Entity as of the respective dates thereof and
the results of operations, cash flows, and changes in capital and
surplus (or stockholders’ equity, as applicable) of such
Insurance Entity for the respective periods then ended. Its
Statutory Statements complied in all material respects with all
applicable Laws when filed or submitted and no material violation
or deficiency has been asserted in writing by any Governmental
Entity with respect to any of its Statutory Statements that have
not been cured or otherwise resolved to the satisfaction of such
Governmental Entity. The statutory balance sheets and income
statements included in its annual Statutory Statements have been
audited by its independent auditors, and it has delivered or made
available to the other party true and complete copies of all audit
opinions related thereto for periods beginning January 1, 2007
through the date hereof. Except as is indicated therein, all assets
that are reflected on its
17
subsidiaries’ Statutory Statements comply
in all material respects with all applicable Insurance Laws
regulating the investments of Insurance Entities and all applicable
Insurance Laws with respect to admitted assets and are in amount at
least equal to the minimum amount required by applicable Insurance
Laws. The financial statements included in its Statutory Statement
accurately reflect in all material respects the extent to which,
pursuant to applicable Laws and Applicable SAP, the applicable
Insurance Entity is entitled to take credit for reinsurance (or any
local equivalent concept).
(c) The loss reserves and other
actuarial amounts of each of its Insurance Entities contained in
its Statutory Statements: ( i ) were determined in
accordance with generally accepted actuarial standards and
principles and other reasonable qualitative methods materially
consistently applied (except as otherwise noted in such financial
statements), ( ii ) complied in all material respects
with applicable Laws and were computed on the basis of
methodologies materially consistent with those used in computing
the corresponding reserves in the prior fiscal years, except as
otherwise noted in the financial statements and notes thereto
included in such Statutory Statements, and ( iii
) include provisions for all actuarial reserves and related
items which are required to be established in accordance with
applicable Law. To its knowledge, no facts or circumstances exist
which would necessitate any material increase in the statutorily
required reserves above those reflected in the most recent balance
sheet included in the Statutory Statements.
(d) Prior to the date of this
Agreement, it has made available to the other party true and
complete copies of all actuarial reports used as the basis for
establishing the reserves for each of its subsidiary Insurance
Entities from and after January 1, 2007, and all material
attachments, addenda, supplements and modifications thereto. To its
knowledge, any information and data furnished by it or any of its
subsidiaries to independent actuaries in connection with the
preparation of such actuarial reports were accurate in all material
respects. To its knowledge, such actuarial reports were based upon
an accurate inventory of Policies and Reinsurance Agreements in
force for it and its subsidiaries, as the case may be, at the
relevant time of preparation and were prepared in conformity in all
material respects with generally accepted actuarial principles and
other reasonable qualitative methods in effect at such time (except
as may be noted therein) and the projections contained therein were
properly prepared in accordance with the assumptions stated
therein.
(e) As of the date of this
Agreement, all reinsurance or retrocession treaties or agreements,
slips, binders, cover notes or other similar arrangements to which
it or any of its subsidiaries is a party or under which it or any
of its subsidiaries has any existing rights, obligations or
liabilities (the “ Reinsurance Agreements ”)
are, and after the consummation of the transactions contemplated
hereby will continue to be, valid and binding obligations of it and
its subsidiaries (to the extent they are parties thereto or bound
thereby) and, to its knowledge, each other party thereto, in
accordance with their terms and are in full force and effect, and
it and each of its subsidiaries (to the extent they are party
thereto or bound thereby) and, to its knowledge, each other party
thereto has performed in all material respects all obligations
required to be performed by it under each Reinsurance Agreement,
except as has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.
Neither it nor any of its subsidiaries has received notice, nor
does it have knowledge, of any violation or default in respect of
any obligation under (or any condition which, with the passage of
time or the giving of notice or both, would result in such a
violation or default), or any intention to cancel, terminate or
change the scope of rights and obligations under, or not to renew,
any Reinsurance Agreement, except, in each case, as has not had and
would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect. Since January 1, 2007, (
i ) neither it nor its subsidiaries have received any
written notice from any party to a Reinsurance Agreement that any
amount of reinsurance ceded by it or such subsidiary to such
counterparty will be uncollectible or otherwise defaulted upon, (
ii ) to its knowledge, no party to a Reinsurance
Agreement under which it or its subsidiary is the cedent is
insolvent or the subject of a rehabilitation, liquidation,
conservatorship, receivership, bankruptcy or similar proceeding, (
iii ) to its knowledge, the financial condition of any
party to a Reinsurance Agreement under which it or its subsidiary
is the cedent is not impaired to the extent that a default
thereunder is reasonably
18
anticipated, ( iv ) there are no
disputes under any Reinsurance Agreement other than disputes in the
ordinary course for which adequate loss reserves have been
established and ( v ) its relevant subsidiary is
entitled under any applicable Law and Applicable SAP to take full
credit in its Statutory Statements for all amounts recoverable by
it pursuant to any Reinsurance Agreement under which it is the
cedent and all such amounts recoverable have been properly recorded
in its books and records of account (if so accounted therefor) and
are properly reflected in its Statutory Statements, except as has
not had and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect.
(f) Except as has not had and would
not be reasonably expected to have, individually or in the
aggregate, a Material Adverse Effect, with respect to any
Reinsurance Agreement for which the ceding insurer party thereto is
taking credit on its most recent Statutory Statements, to its
knowledge, from and after January 1, 2007 ( i
) there has been no separate written or oral agreement between
such ceding insurer and the assuming reinsurer that would under any
circumstances reduce, limit, mitigate or otherwise affect any
actual or potential loss to the parties under any such Reinsurance
Agreement, other than inuring contracts that are explicitly defined
in any such Reinsurance Agreement, ( ii ) for each such
Reinsurance Agreement entered into, renewed or amended on or after
January 1, 2007, for which risk transfer is not reasonably
considered to be self-evident to the extent required by any
applicable provisions of SSAP No. 62, documentation concerning
the economic intent of the transaction and the risk transfer
analysis evidencing the proper accounting treatment is available
for review by the relevant Governmental Entities for each of it and
its subsidiaries, ( iii ) its subsidiary that is a
party thereto, and to its knowledge, any other party thereto,
complies and has complied from and after January 1, 2007 with
any applicable requirements set forth in SSAP No. 62, and (
iv ) such Insurance Entity has and had since
January 1, 2007 appropriate controls in place to monitor the
use of reinsurance and comply with the provisions of SSAP
No. 62.
(g) All policies, policy forms,
binders, slips, treaties, certificates, insurance or reinsurance
contracts or participation agreements and other agreements of
insurance or reinsurance, whether individual or group (including
all applications, supplements, endorsements, riders and ancillary
agreements in connection therewith) and all amendments,
applications, brochures, illustrations and certificates pertaining
thereto (the “ Policies ”), in effect as of the
date of this Agreement, that are issued by it or its subsidiaries
and any and all marketing materials have been, to the extent
required under applicable Law, filed with or submitted to and not
objected to by such Governmental Entity within the period provided
for objection, and such Policies and marketing materials comply
with the Insurance Laws applicable thereto and have been
administered in accordance therewith, except as has not had and
would not be reasonably expected to have, individually or in the
aggregate, a Material Adverse Effect. All premium rates established
by it or its subsidiaries that are required to be filed with or
submitted to or approved by Governmental Entities have been so
filed, submitted or approved, the premiums charged conform thereto
and such premiums comply with the Insurance Laws applicable
thereto, except as has not had and would not be reasonably expected
to have, individually or in the aggregate, a Material Adverse
Effect.
(h) To its knowledge, each insurance
agent, general agent, agency, producer, broker, reinsurance
intermediary, program manager, managing general agent and managing
general underwriter currently selling, issuing or underwriting
business for or on behalf of it or its subsidiaries (including it
and its subsidiaries’ salaried employees) (each, an “
Agent ”) was duly licensed for the type of activity
and business conducted or written, sold, produced, underwritten or
managed. To its knowledge, each program manager, managing general
agent, third party administrator or claims adjuster or manager, at
the time such person managed or administered business (including
the administration, handling or adjusting of claims) for or on
behalf of it or its subsidiaries (each, an “
Administrator ”) was duly licensed for the type of
activity conducted. To its knowledge, no Agent or Administrator has
materially violated or is currently in violation in any material
respect of any term or provision of any Law applicable to the
writing, sale, production, underwriting or administration of
business for it or its subsidiaries, except for such failures or
such violations which have been cured, that have been resolved or
settled through agreements with
19
applicable Governmental Entities or that are
barred by an applicable statute of limitations. Each Agent was
appointed and compensated by it or its subsidiaries in compliance
in all material respects with applicable Law and all processes and
procedures used in making inquiries with respect of such Agent were
undertaken in compliance in all material respects with applicable
Law. No Agent has binding authority on behalf of it or its
subsidiaries. As of the date of this Agreement, no Agent accounting
individually for 1% or more of the total gross premiums of all of
its Insurance Entities for the year ended December 31, 2008,
has indicated to it or its subsidiaries in writing or, to its
knowledge, orally that such Agent will be unable or unwilling to
continue its relationship as an Agent with it or its subsidiary
within twelve months after the date hereof.
(i) Each of its Insurance Entities
has duly and timely filed all reports or other filings required to
be filed with any insurance regulatory authority in the manner
prescribed therefor under applicable Laws and Permits and no
Governmental Entity has asserted any deficiency or violation with
respect thereto, except as has been cured or resolved to the
satisfaction of the Government Entity or except, in each case, as
has not had and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect.
Without limiting the foregoing, each of its and its
subsidiaries’ submissions, reports or other filings under
applicable insurance holding company statutes or other applicable
Insurance Laws with respect to contracts, agreements, arrangements
and transactions between or among Insurance Entities and their
affiliates, and all contracts, agreements, arrangements and
transactions in effect between any subsidiary that is an Insurance
Entity and any affiliate are in compliance with the requirements of
all applicable insurance holding company statutes or other such
Insurance Laws and all required approvals or deemed approvals of
insurance regulatory authorities with respect thereto have been
received or obtained, except as has not had and would not
reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect.
(j) Copies (which are complete and
correct in all material respects) of all analyses, reports and
other data prepared by or on behalf of any of its Insurance
Entities or submitted by or on behalf of any such Insurance Entity
to any insurance regulatory authority relating to risk based
capital calculations or Insurance Regulatory Information Systems
ratios have been provided to the other party prior to the date of
this Agreement.
(k) Except for regular periodic
assessments in the ordinary course of business, there are no
material unpaid claims and assessments against it or its
subsidiaries, whether or not due, by any insurance guaranty
association (in connection with that association’s fund
relating to insolvent insurers), joint underwriting association,
residual market facility or assigned risk pool. No such material
claim or assessment is pending and neither it nor any subsidiary
has received written notice of any such material claim or
assessment against it or its subsidiaries by any insurance guaranty
association, joint underwriting association, residual market
facility or assigned risk pool.
(l) Since July 2, 2007, Validus
and/or any of its subsidiaries which participate in Lloyd’s:
(i) has not participated on any Lloyd’s syndicate other
than syndicate 1183; (ii) has not agreed to sell, transfer or
“drop” any of its rights to participate in a
Lloyd’s syndicate or offered to acquire rights to participate
on a Lloyd’s syndicated; (iii) has complied with the
franchise standards (including principles and minimum standards,
guidance and advice) issued by Lloyd’s and (iv) all
documents relating to the participation of it or any of its
subsidiaries’ participation at Lloyd’s are in
Lloyd’s standard form and have not been amended in any way,
including the standard managing agent’s agreement, in each
case, except as had not had and would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse
Effect.
(m) Since July 2, 2007:
(i) all funds held on behalf of Lloyd’s syndicate 1183
are held in accordance with the terms of the relevant premiums
trust deed or other deposit arrangement as required by the
bye-laws, regulations, codes of practice and mandatory directions
and requirements governing the conduct and management of
underwriting business at Lloyd’s from time to time and the
provisions of any
20
deed, agreement or undertaking executed, made or
given for compliance with Lloyd’s requirements from time to
time (“ Lloyd’s Regulations ”) and
(ii) Validus and/or any of its subsidiaries required to do so
have complied in all material respects with all relevant
regulations, directions, notices and requirements in relation to
the maintenance of Funds at Lloyd’s (as defined in the
Lloyd’s Membership Byelaw (No. 5 of 2005)) in accordance with
Lloyd’s Regulations and any directions imposed on it or any
of its subsidiaries by Lloyd’s.
3.13 Investments; Derivatives
.
(a) The information provided by it
to the other party related to its investment assets, including
bonds, notes, debentures, mortgage loans, real estate, collateral
loans, derivatives (including swaps, swaptions, caps, floors,
foreign exchange, and options or forward agreements) and all other
instruments of indebtedness, stocks, partnership or joint venture
interests and all other equity interests, certificates issued by or
interests in trusts, alternative investments and direct or indirect
investments in hedge funds, whether entered into for its own or its
subsidiaries or their customers’ accounts (such investment
assets, together with all investment assets held between such date
and the Closing Date are referred to herein as the “
Investment Assets ”) is true and complete in all
material respects as of May 31, 2009.
(b) As of the date of this
Agreement, to its knowledge, none of the Investment Assets is in
default in the payment of principal or interest or
dividends.
(c) As of the date of this
Agreement, to its knowledge, the Investment Assets comply in all
material respects with, and the acquisition